Resources

Helpful references to learn more about DecisionDx-Melanoma

Hear from experts and patients alike and learn more about DecisionDx-Melanoma’s precise, personalized and proven results.

Expert opinions on the treatment and management of cutaneous melanoma

  • Play interview with Muhammad A Salamat, MD on uncovering the limitations of traditional approaches to risk assessment

    Uncovering the limitations of traditional approaches to risk assessment

  • Play interview with Shannon Trotter, DO, on how DecisionDx-Melanoma can accurately predict individual risk of recurrence and/or metastasis

    How DecisionDx-Melanoma can accurately predict individual risk of recurrence and/or metastasis

  • Play interview with Scott Dinehart, MD on improving patient selection for the SLNB surgical procedure

    Improving patient selection for the SLNB surgical procedure

  • Play interview with Eric Whiteman, MD, FACS, on how Castle us changing the management of dermatologic cancers

    How Castle is changing the management of dermatologic cancers 

  • Play interview with John Vetto, MD, on the role of molecular prognostic tests in managing dermatologic cancers

    The role of molecular prognostic tests in managing dermatologic cancers

Hear a patient's journey with DecisionDx-Melanoma

As a stage III melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.

Order the DecisionDx-Melanoma test

Order Test

Explore on-demand webinars

  • Incorporating prognostic gene expression profiling in the management of skin cancer

    Faculty: Shannon Trotter, DO Oakview Dermatology

    James Sligh, MD, PhD Bay Pines VA Medical Center

     

    CME/CE: CME (1.0 AMA PRA Category 1 Credit(s)) 

    Access Now

  • Use of a genomic-based prognostic tool to inform clinical decisions for patients with cutaneous melanoma

    Faculty: Shannon Trotter, DO Oakview Dermatology

    Joseph Michael Guenther, MD
    St. Elizabeth Physicians

     

    CME/CE: CME (Credit Expiration Date: July 31, 2021)

    Access Now

  • Incorporating DecisionDx-Melanoma into clinical practice: molecular information for personalized management decisions

    Faculty: Darrell S. Rigel, MD, FAAD Clinical Professor of Dermatology New York University Grossman Medical School
    St. Elizabeth Physicians

     

    CME/CE: N/A

    Access Now

  • Castle Biosciences - revolutionizing gene expression profiling in clinical management of dermatologic cancers

    Faculty: Aarron Farberg, MD, FAAD Baylor University Medical Center, Dallas TX

     

    CME/CE: N/A

    Access Now

  • 31-GEP: sentinel lymph node biopsy guidance

    Faculty: John Vetto, MD, FACS

     

    CME/CE: N/A

    Access Now

  • DecisionDx-Melanoma: predicting individualized risk of recurrence

    Faculty: James Sligh, MD, PhD

     

    CME/CE: N/A

    Access Now

Learn about related tests

View All Tests